Literature DB >> 12547248

Iron metabolism and mitochondrial abnormalities in Friedreich ataxia.

Massimo Pandolfo1.   

Abstract

Friedreich ataxia is an autosomal recessive disease causing degeneration in the central and peripheral nervous system, cardiomyopathy, skeletal abnormalities and increased risk of diabetes. It is caused by deficiency of frataxin, a highly conserved nuclear-encoded mitochondrial protein. The genetic mutation found in 98% of Friedreich ataxia chromosomes is the unstable hyperexpansion of a GAA triplet repeat in the first intron of the gene. The expanded GAA repeat, by adopting an abnormal triple helical structure, impairs frataxin transcription. Longer repeats cause a more profound frataxin deficiency and are associated with earlier onset and increased severity of the disease. Yeast cells deficient in the frataxin homologue (Deltayfh1) become unable to carry out oxidative phosphorylation, lose mitochondrial DNA, accumulate iron in mitochondria, show unregulated high expression of high affinity iron uptake, and have an increased sensitivity to oxidative stress. Loss of respiratory competence in Deltayfh1 is iron-dependent. Additional properties of these cells include a deficiency of iron-sulfur cluster containing proteins (ISPs) and impaired iron efflux out of mitochondria. Evidence of oxidative stress, mitochondrial dysfunction, deficiency of multiple ISPs and iron deposits are also found in the human disease and in mouse models. The primary function of frataxin is still unknown, however much recent evidence suggests that it enhances iron-sulfur cluster synthesis and protects iron from free radical-generating reactions. The search for frataxin function stimulated more investigations on the role of mitochondria in cellular iron homeostasis. Their results suggest that these organelles may play a central role in controlling iron homeostasis, which is not surprising considering that they are the major cellular site where this metal is utilized. I propose a model, valid in yeast as well as in higher eukaryotes, in which iron transport into mitochondria is directly coupled to its uptake at the cell membrane and iron transport out of mitochondria depends on adequate iron-sulfur cluster synthesis. Regulatory mechanisms in the cytosol would then sense a post-mitochondrial iron pool. Much circumstantial evidence from genetically manipulated yeast and from human diseases supports this model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12547248     DOI: 10.1006/bcmd.2002.0591

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  17 in total

Review 1.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

2.  Variations of frataxin protein levels in normal individuals.

Authors:  Therese Boehm; Barbara Scheiber-Mojdehkar; Britta Kluge; Hans Goldenberg; Franco Laccone; Brigitte Sturm
Journal:  Neurol Sci       Date:  2010-05-27       Impact factor: 3.307

Review 3.  The structure and function of frataxin.

Authors:  Krisztina Z Bencze; Kalyan C Kondapalli; Jeremy D Cook; Stephen McMahon; César Millán-Pacheco; Nina Pastor; Timothy L Stemmler
Journal:  Crit Rev Biochem Mol Biol       Date:  2006 Sep-Oct       Impact factor: 8.250

4.  Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2.

Authors:  Paul T Kotzbauer; Adam C Truax; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

5.  Targeting chelatable iron as a therapeutic modality in Parkinson's disease.

Authors:  David Devos; Caroline Moreau; Jean Christophe Devedjian; Jérome Kluza; Maud Petrault; Charlotte Laloux; Aurélie Jonneaux; Gilles Ryckewaert; Guillaume Garçon; Nathalie Rouaix; Alain Duhamel; Patrice Jissendi; Kathy Dujardin; Florent Auger; Laura Ravasi; Lucie Hopes; Guillaume Grolez; Wance Firdaus; Bernard Sablonnière; Isabelle Strubi-Vuillaume; Noel Zahr; Alain Destée; Jean-Christophe Corvol; Dominik Pöltl; Marcel Leist; Christian Rose; Luc Defebvre; Philippe Marchetti; Z Ioav Cabantchik; Régis Bordet
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

6.  Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function.

Authors:  Mary A Selak; Elise Lyver; Elizabeth Micklow; Eric C Deutsch; Ozlem Onder; Nur Selamoglu; Claire Yager; Simon Knight; Martin Carroll; Fevzi Daldal; Andrew Dancis; David R Lynch; Jean-Emmanuel Sarry
Journal:  Mitochondrion       Date:  2010-12-13       Impact factor: 4.160

7.  Frataxin, iron-sulfur clusters, heme, ROS, and aging.

Authors:  Eleonora Napoli; Franco Taroni; Gino A Cortopassi
Journal:  Antioxid Redox Signal       Date:  2006 Mar-Apr       Impact factor: 8.401

8.  A precious metal: Iron, an essential nutrient for all cells.

Authors:  G Cairo; F Bernuzzi; S Recalcati
Journal:  Genes Nutr       Date:  2006-03       Impact factor: 5.523

9.  Iron-induced oligomerization of yeast frataxin homologue Yfh1 is dispensable in vivo.

Authors:  Kerman Aloria; Brenda Schilke; Amy Andrew; Elizabeth A Craig
Journal:  EMBO Rep       Date:  2004-11       Impact factor: 8.807

10.  Mitochondrial iron accumulation with age and functional consequences.

Authors:  Arnold Y Seo; Jinze Xu; Stephane Servais; Tim Hofer; Emanuele Marzetti; Stephanie E Wohlgemuth; Mitchell D Knutson; Hae Young Chung; Christiaan Leeuwenburgh
Journal:  Aging Cell       Date:  2008-10       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.